Accelerating Accessibility of CAR-T/NK therapies–Are AlloCARs and rapid manufacturing platforms...

[引用][C] CAR T-cell therapy comes of age: Introductory editorial for the special issue

JN Brudno - Seminars in hematology, 2024 - pubmed.ncbi.nlm.nih.gov
相关文章